Reporting owner · Q3 2026 · CIK 2010224

Lantheus Alpha Therapy, LLC: insider trades.

Lantheus Alpha Therapy, LLC reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($1.3M), across 1 company.

Transactions
5
Purchases (P)
0
Sales (S)
5
Companies
1
Name as filed
Lantheus Alpha Therapy, LLC

Companies

CompanyRelationshipTransactions
Perspective Therapeutics, Inc. (CATX)TenPercentOwner5

Transactions

5 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-04Perspective Therapeutics, Inc.S167,149$3.1511,273,364Form 4
2026-09-03Perspective Therapeutics, Inc.S80,783$3.1111,440,513Form 4
2026-09-02Perspective Therapeutics, Inc.S42,129$3.1111,521,296Form 4
2026-09-01Perspective Therapeutics, Inc.S35,769$3.1211,563,425Form 4
2026-08-31Perspective Therapeutics, Inc.S78,145$3.1411,599,194Form 4

Questions

What stock did Lantheus Alpha Therapy, LLC buy or sell?

Lantheus Alpha Therapy, LLC reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($1.3M), across 1 company.

Is Lantheus Alpha Therapy, LLC the same person as other filers with this name?

This page covers SEC CIK 2010224 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/lantheus-alpha-therapy-llc-2010224.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.